Investing
The startup provides an app that rewards patients for completing health behaviors like taking medications or monitoring blood pressure.
Bill Taranto, president of Merck Global Health Innovation Fund, talks about the funding environment and how digital health companies can ensure investment this year.
Venture capital panelists discussed how the collapse of Silicon Valley Bank earlier this month could affect digital health at ViVE 2023.
Also, Roche and Astellas have combined their diabetes management solutions.
GV, Thrive Capital and Salesforce Ventures led the company's seed funding round.
The startup previously raised $14 million in 2020.
The company will use the funds to continue its growth in the U.S.
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
It also received backing from the founding members of Grab and Zalora.
Blood-collection device-maker Vitestro, tech-enabled baby bottle designer Emulait, digital health support platform Reveal HealthTech and AI-based testing platform PocDoc also received funding.